MASLD y riesgo de cáncer de mama: el papel de las exoxomas derivadas de hepatocitos

Thomas Marjot1

  • 1Oxford Centre for Diabetes Endocrinology and Metabolism (OCDEM), Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, UK; Translational Gastroenterology and Liver Unit (TGLU), Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, UK.

Journal of hepatology
|February 24, 2026
PubMed
Resumen

No abstract available in PubMed .